FDA Approves Teal Health's Teal Wand™--The First and Only At-Home Self-Collection Device for Cervical Cancer Screening, Introducing a Comfortable Alternative to In-Person Screening

Women can now collect their own sample from the privacy of home, no speculum required, and mail it to a certified lab to be tested on the same test as the doctor's office, with the same accuracy.

SAN FRANCISCO, May 9, 2025 -- Teal Health^®, a women's health company on a mission to eliminate cervical cancer, today announced the Food and Drug Administration's (FDA) approval of the Teal Wand^™, the first and only at-home vaginal sample self-collection device for cervical cancer screening in the United States. Cervical cancer screenings, commonly referred to as the Pap smear, are critical to a woman's health, but they are inconvenient and uncomfortable for most. Now women have a new way to screen that is as accurate as going to the doctor's office, comfortable, and done from home. The Teal Wand is a prescription device that will soon be available at getteal.com for individuals aged 25–65 at average risk. The at-home screening includes both the Teal Wand collection kit and an end-to-end telehealth service providing virtual access to Teal medical providers who prescribe the kit, review the results from the lab, and support women throughout their at-home screening experience.